U.S. Female External Catheter Market Size, Share & Trends Analysis Report By Material (Silicone, Latex), By Application (Diabetes, Strokes), By Area Of Incontinence, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Market Size & Trends
The U.S. female external catheter market size was valued at USD 347.93 million in 2023 and is projected t%li%grow at a CAGR of 5.26% from 2024 t%li%2030. The market is driven by the increasing demand for innovative and effective solutions for managing urinary incontinence and catheterization in women. Female external catheters are designed t%li%provide a safe, comfortable, and hygienic alternative t%li%traditional indwelling urethral catheters, which can be associated with complications such as urinary tract infections and bladder damage. Trends that are shaping the U.S. market include the growing demand for female external catheters that prioritize comfort, hygiene, and ease of use. The rise of customizable and smart external catheters reflects a growing emphasis on personalized medicine and patient-centered care, and the integration of telemedicine and remote monitoring technologies is becoming increasingly important in the management of urinary incontinence and catheterization.
Prevalence of chronic diseases, such as diabetes, Alzheimer’s, Parkinson’s, and various other conditions, is significantly increasing, leading t%li%a considerable rise in hospital admission rates, thus driving the growth of the U.S. market for female external catheter. According t%li%the National Diabetes Statistics Report, in 2021, more than 41 million people of all ages (12.5% of the U.S. population) had diabetes, but approximately 9.4 million adults (23.5% of adults with diabetes) were unaware that they had the condition. Notably, the prevalence of diabetes among adults aged 65 years or older increased t%li%an alarming 30.4%. According t%li%the America's Health Rankings report by the United Health Foundation, approximately 29.3 million adults, equivalent t%li%11.2% of the overall population, reported having three or more chronic health conditions in 2022. Thus, due t%li%the increasing prevalence of chronic diseases and the subsequent surge in hospitalizations, the demand for female external catheter is expected t%li%grow, fueling growth in the U.S. market. Further, the CDC Behavioral Risk Factor Surveillance System, in 2022 reported that West Virginia (41%), Louisiana (40.1%), Oklahoma (40.0%), and Mississippi (39.5%) had the highest rates of adult obesity in the same year. This makes the current increase in the obese population a significant factor contributing t%li%the growth of the Female External Catheter market in this region.
Market Characteristics & Concentration
The market growth stage is medium, and pace of the market growth is accelerating. The U.S. market for female external catheter is characterized by increasing cases of chronic diseases, growing prevalence of urinary incontinence among women coupled with growing demand for discreet and convenient urinary management solutions for women.
Key strategies implemented by players and government entities in the U.S. market for female external catheter are product launch, expanding distribution channels, partnerships, collaboration, marketing & awareness campaigns, and other strategies.
The U.S. market has witnessed a moderate t%li%high degree of innovation in recent years. The market has seen the introduction of new products with advanced features, improved designs, and enhanced materials, which have significantly impacted the industry. One of the key drivers of innovation is the increasing demand for discreet and comfortable products that cater t%li%the specific needs of women with urinary incontinence. As a result, manufacturers have developed products with ergonomic designs, soft and breathable materials, and advanced drainage systems.
The market is regulated by the Food and Drug Administration (FDA), which oversees the safety and effectiveness of medical devices, including catheters. The FDA's regulatory framework provides a framework for the development, testing, and approval of new products. Female external catheters are classified as Class I or II devices, depending on their level of risk. Class I devices are considered low-risk and are subject t%li%minimal regulation, while Class II devices are considered moderate-risk and are subject t%li%more stringent regulations.
Regulations often set standards for safety and efficacy, driving manufacturers t%li%invest in R&D t%li%meet these requirements. Companies prioritize the development of innovative features and advancements in existing technologies t%li%not only meet regulatory requirements but als%li%t%li%ultimately enhance patient outcomes and improve healthcare quality. Compliance with these regulations is mandatory, which can increase the cost and time required for product development and market entry. Additionally, Medicare and Medicaid policies influence the procurement strategies of hospitals, especially with regards t%li%reimbursement rates and coverage for advanced medical equipment.
Market players are focusing on expanding their product portfolios t%li%cater t%li%a broader range of patient needs. The use of advanced materials, such as nanomaterials and biodegradable materials, is expected t%li%increase in the development of new products. These materials offer improved properties, such as enhanced lubricity, antimicrobial activity, and biocompatibility. Further, private labeling opportunities are increasing as manufacturers partner with distributors t%li%create customized products for specific retailers or patients. This trend is driven by the growing demand for personalized healthcare and the need for tailored products that meet specific patient needs. In addition, new entrants are expected t%li%enter the market, particularly in the areas of innovative materials and digital health integration. Established players will need t%li%adapt t%li%these changes t%li%maintain market share and remain competitive.
Companies focus on addressing several patient demographics or meeting specific therapeutic requirements. The market includes large, established companies such as Stryker, BD, Boehringer Laboratories, LLC., Hollister Incorporated, and Consure Medical which offer a broad range of products and have significant market shares. Due t%li%an emphasis of companies in developing customized solutions for certain specializations in the market, this specialization contributes t%li%market fragmentation.
Forming strategic partnerships or collaborations with local distributors, healthcare providers, and key opinion leaders can facilitate market entry and accelerate adoption. Collaborating with established entities can provide valuable insights int%li%regional market nuances, regulatory requirements, and customer preferences.
U.S. Female External Catheter Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the U.S. female external catheter market report based on material, application, area of incontinence, end-use, and region
Market Size & Trends
The U.S. female external catheter market size was valued at USD 347.93 million in 2023 and is projected t%li%grow at a CAGR of 5.26% from 2024 t%li%2030. The market is driven by the increasing demand for innovative and effective solutions for managing urinary incontinence and catheterization in women. Female external catheters are designed t%li%provide a safe, comfortable, and hygienic alternative t%li%traditional indwelling urethral catheters, which can be associated with complications such as urinary tract infections and bladder damage. Trends that are shaping the U.S. market include the growing demand for female external catheters that prioritize comfort, hygiene, and ease of use. The rise of customizable and smart external catheters reflects a growing emphasis on personalized medicine and patient-centered care, and the integration of telemedicine and remote monitoring technologies is becoming increasingly important in the management of urinary incontinence and catheterization.
Prevalence of chronic diseases, such as diabetes, Alzheimer’s, Parkinson’s, and various other conditions, is significantly increasing, leading t%li%a considerable rise in hospital admission rates, thus driving the growth of the U.S. market for female external catheter. According t%li%the National Diabetes Statistics Report, in 2021, more than 41 million people of all ages (12.5% of the U.S. population) had diabetes, but approximately 9.4 million adults (23.5% of adults with diabetes) were unaware that they had the condition. Notably, the prevalence of diabetes among adults aged 65 years or older increased t%li%an alarming 30.4%. According t%li%the America's Health Rankings report by the United Health Foundation, approximately 29.3 million adults, equivalent t%li%11.2% of the overall population, reported having three or more chronic health conditions in 2022. Thus, due t%li%the increasing prevalence of chronic diseases and the subsequent surge in hospitalizations, the demand for female external catheter is expected t%li%grow, fueling growth in the U.S. market. Further, the CDC Behavioral Risk Factor Surveillance System, in 2022 reported that West Virginia (41%), Louisiana (40.1%), Oklahoma (40.0%), and Mississippi (39.5%) had the highest rates of adult obesity in the same year. This makes the current increase in the obese population a significant factor contributing t%li%the growth of the Female External Catheter market in this region.
Market Characteristics & Concentration
The market growth stage is medium, and pace of the market growth is accelerating. The U.S. market for female external catheter is characterized by increasing cases of chronic diseases, growing prevalence of urinary incontinence among women coupled with growing demand for discreet and convenient urinary management solutions for women.
Key strategies implemented by players and government entities in the U.S. market for female external catheter are product launch, expanding distribution channels, partnerships, collaboration, marketing & awareness campaigns, and other strategies.
The U.S. market has witnessed a moderate t%li%high degree of innovation in recent years. The market has seen the introduction of new products with advanced features, improved designs, and enhanced materials, which have significantly impacted the industry. One of the key drivers of innovation is the increasing demand for discreet and comfortable products that cater t%li%the specific needs of women with urinary incontinence. As a result, manufacturers have developed products with ergonomic designs, soft and breathable materials, and advanced drainage systems.
The market is regulated by the Food and Drug Administration (FDA), which oversees the safety and effectiveness of medical devices, including catheters. The FDA's regulatory framework provides a framework for the development, testing, and approval of new products. Female external catheters are classified as Class I or II devices, depending on their level of risk. Class I devices are considered low-risk and are subject t%li%minimal regulation, while Class II devices are considered moderate-risk and are subject t%li%more stringent regulations.
Regulations often set standards for safety and efficacy, driving manufacturers t%li%invest in R&D t%li%meet these requirements. Companies prioritize the development of innovative features and advancements in existing technologies t%li%not only meet regulatory requirements but als%li%t%li%ultimately enhance patient outcomes and improve healthcare quality. Compliance with these regulations is mandatory, which can increase the cost and time required for product development and market entry. Additionally, Medicare and Medicaid policies influence the procurement strategies of hospitals, especially with regards t%li%reimbursement rates and coverage for advanced medical equipment.
Market players are focusing on expanding their product portfolios t%li%cater t%li%a broader range of patient needs. The use of advanced materials, such as nanomaterials and biodegradable materials, is expected t%li%increase in the development of new products. These materials offer improved properties, such as enhanced lubricity, antimicrobial activity, and biocompatibility. Further, private labeling opportunities are increasing as manufacturers partner with distributors t%li%create customized products for specific retailers or patients. This trend is driven by the growing demand for personalized healthcare and the need for tailored products that meet specific patient needs. In addition, new entrants are expected t%li%enter the market, particularly in the areas of innovative materials and digital health integration. Established players will need t%li%adapt t%li%these changes t%li%maintain market share and remain competitive.
Companies focus on addressing several patient demographics or meeting specific therapeutic requirements. The market includes large, established companies such as Stryker, BD, Boehringer Laboratories, LLC., Hollister Incorporated, and Consure Medical which offer a broad range of products and have significant market shares. Due t%li%an emphasis of companies in developing customized solutions for certain specializations in the market, this specialization contributes t%li%market fragmentation.
Forming strategic partnerships or collaborations with local distributors, healthcare providers, and key opinion leaders can facilitate market entry and accelerate adoption. Collaborating with established entities can provide valuable insights int%li%regional market nuances, regulatory requirements, and customer preferences.
U.S. Female External Catheter Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the U.S. female external catheter market report based on material, application, area of incontinence, end-use, and region
- Material Outlook (Revenue, USD Million, 2018 - 2030)
- Silicone
- Latex
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Diabetes
- Strokes
- Alzheimer's disease
- Parkinson's disease
- Spinal Cord Injury
- Bladder Cancer
- Ovarian Cancer
- Multiple Sclerosis
- Others
- Area of Incontinence Outlook (Revenue, USD Million, 2018 - 2030)
- Stress Urinary Incontinence
- Urge/OAB (Overactive Bladder)
- Overflow
- Functional
- Mixed
- Reflex
- Severe Incontinence
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Home Care
- Hospitals
- Other End-use
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. FEMALE EXTERNAL CATHETER MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of Urinary Incontinence (UI)
3.2.1.2. Growing awareness about UI and its treatment options
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations on product design, material, and manufacturing processes
3.2.2.2. Alternative treatment options
3.2.3. Market Opportunities Analysis
3.2.3.1. Increased focus on comfort and discretion
3.2.3.2. Advancements in technology
3.2.3.3. Expansion into online sales channels
3.3. U.S. Female External Catheter Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
CHAPTER 4. U.S. FEMALE EXTERNAL CATHETER MARKET: MATERIAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Female External Catheter Market Material Movement Analysis
4.3. U.S. Female External Catheter Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
4.4. Silicone
4.4.1. Silicone U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Latex
4.5.1. Latex U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. FEMALE EXTERNAL CATHETER MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Female External Catheter Market Application Movement Analysis
5.3. U.S. Female External Catheter Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Diabetes
5.4.1. Diabetes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Strokes
5.5.1. Strokes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Alzheimer's disease
5.6.1. Alzheimer's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Parkinson's disease
5.7.1. Parkinson's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Spinal Cord Injury
5.8.1. Spinal Cord Injury U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Bladder Cancer
5.9.1. Bladder Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Ovarian Cancer
5.10.1. Ovarian Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Multiple Sclerosis
5.11.1. Multiple Sclerosis U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Others
5.12.1. Others U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. FEMALE EXTERNAL CATHETER MARKET: AREA OF INCONTINENCE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Female External Catheter Market Area of Incontinence Movement Analysis
6.3. U.S. Female External Catheter Market Size & Trend Analysis, by Area of Incontinence, 2018 to 2030 (USD Million)
6.4. Stress Urinary Incontinence
6.4.1. Stress Urinary Incontinence U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Urge/OAB (Overactive Bladder)
6.5.1. Urge/OAB (Overactive Bladder) U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Overflow
6.6.1. Overflow U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Functional
6.7.1. Functional U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. FEMALE EXTERNAL CATHETER MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. U.S. Female External Catheter Market End-Use Movement Analysis
7.3. U.S. Female External Catheter Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
7.4. Home Care
7.4.1. Home Care U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospitals
7.5.1. Hospitals U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Other End-Use
7.6.1. Other End-Use U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. U.S. FEMALE EXTERNAL CATHETER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY MATERIAL, BY APPLICATION, BY AREA OF INCONTINENCE, BY END-USE
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. U.S.
8.3.1. U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. South
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Scenario
8.3.2.4. Reimbursement Scenario
8.3.2.5. South U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. West
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Scenario
8.3.3.4. Reimbursement Scenario
8.3.3.5. West U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. Midwest
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Scenario
8.3.4.4. Reimbursement Scenario
8.3.4.5. Midwest U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Northeast
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Scenario
8.3.5.4. Reimbursement Scenario
8.3.5.5. Northeast U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. BD
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Stryker
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Product Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. Boehringer Laboratories, LLC.
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Product Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Consure Medical
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Product Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Hollister Incorporated
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Product Benchmarking
9.2.5.4. Strategic Initiatives
9.3. Heat Map Analysis/ Company Market Position Analysis
9.4. Estimated Company Market Share Analysis, 2023
9.5. List of Other Key Market Players
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. FEMALE EXTERNAL CATHETER MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of Urinary Incontinence (UI)
3.2.1.2. Growing awareness about UI and its treatment options
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations on product design, material, and manufacturing processes
3.2.2.2. Alternative treatment options
3.2.3. Market Opportunities Analysis
3.2.3.1. Increased focus on comfort and discretion
3.2.3.2. Advancements in technology
3.2.3.3. Expansion into online sales channels
3.3. U.S. Female External Catheter Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
CHAPTER 4. U.S. FEMALE EXTERNAL CATHETER MARKET: MATERIAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Female External Catheter Market Material Movement Analysis
4.3. U.S. Female External Catheter Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
4.4. Silicone
4.4.1. Silicone U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Latex
4.5.1. Latex U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. FEMALE EXTERNAL CATHETER MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Female External Catheter Market Application Movement Analysis
5.3. U.S. Female External Catheter Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Diabetes
5.4.1. Diabetes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Strokes
5.5.1. Strokes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Alzheimer's disease
5.6.1. Alzheimer's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Parkinson's disease
5.7.1. Parkinson's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Spinal Cord Injury
5.8.1. Spinal Cord Injury U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Bladder Cancer
5.9.1. Bladder Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Ovarian Cancer
5.10.1. Ovarian Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Multiple Sclerosis
5.11.1. Multiple Sclerosis U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Others
5.12.1. Others U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. FEMALE EXTERNAL CATHETER MARKET: AREA OF INCONTINENCE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Female External Catheter Market Area of Incontinence Movement Analysis
6.3. U.S. Female External Catheter Market Size & Trend Analysis, by Area of Incontinence, 2018 to 2030 (USD Million)
6.4. Stress Urinary Incontinence
6.4.1. Stress Urinary Incontinence U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Urge/OAB (Overactive Bladder)
6.5.1. Urge/OAB (Overactive Bladder) U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Overflow
6.6.1. Overflow U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Functional
6.7.1. Functional U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. FEMALE EXTERNAL CATHETER MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. U.S. Female External Catheter Market End-Use Movement Analysis
7.3. U.S. Female External Catheter Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
7.4. Home Care
7.4.1. Home Care U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospitals
7.5.1. Hospitals U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Other End-Use
7.6.1. Other End-Use U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. U.S. FEMALE EXTERNAL CATHETER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY MATERIAL, BY APPLICATION, BY AREA OF INCONTINENCE, BY END-USE
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. U.S.
8.3.1. U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. South
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Scenario
8.3.2.4. Reimbursement Scenario
8.3.2.5. South U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. West
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Scenario
8.3.3.4. Reimbursement Scenario
8.3.3.5. West U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. Midwest
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Scenario
8.3.4.4. Reimbursement Scenario
8.3.4.5. Midwest U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Northeast
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Scenario
8.3.5.4. Reimbursement Scenario
8.3.5.5. Northeast U.S. Female External Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. BD
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Stryker
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Product Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. Boehringer Laboratories, LLC.
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Product Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Consure Medical
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Product Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Hollister Incorporated
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Product Benchmarking
9.2.5.4. Strategic Initiatives
9.3. Heat Map Analysis/ Company Market Position Analysis
9.4. Estimated Company Market Share Analysis, 2023
9.5. List of Other Key Market Players
LIST OF TABLES
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Female External Catheter Market, by Region, 2018 - 2030 (USD Million)
Table 4. U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 5. U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 6. U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 7. U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 8. South U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 9. South U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 10. South U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 11. South U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 12. West U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 13. West U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 14. West U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 15. West U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 16. Midwest U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 17. Midwest U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 18. Midwest U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 19. Midwest U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 20. Northeast U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 21. Northeast U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 22. Northeast U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 23. Northeast U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 24. Participant’s Overview
Table 25. Financial Performance
Table 26. Product Benchmarking
Table 27. Strategic Initiatives
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Female External Catheter Market, by Region, 2018 - 2030 (USD Million)
Table 4. U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 5. U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 6. U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 7. U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 8. South U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 9. South U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 10. South U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 11. South U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 12. West U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 13. West U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 14. West U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 15. West U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 16. Midwest U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 17. Midwest U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 18. Midwest U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 19. Midwest U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 20. Northeast U.S. Female External Catheter Market, by Material, 2018 - 2030 (USD Million)
Table 21. Northeast U.S. Female External Catheter Market, by Application, 2018 - 2030 (USD Million)
Table 22. Northeast U.S. Female External Catheter Market, by Area of Incontinence, 2018 - 2030 (USD Million)
Table 23. Northeast U.S. Female External Catheter Market, by End-Use, 2018 - 2030 (USD Million)
Table 24. Participant’s Overview
Table 25. Financial Performance
Table 26. Product Benchmarking
Table 27. Strategic Initiatives
LIST OF FIGURES
Fig. 1 Transdermal Skin Patches market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Transdermal Skin Patches market: Type movement analysis
Fig. 17 Transdermal Skin Patches market: Type segment dashboard
Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Transdermal Skin Patches market: Application movement analysis
Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Regional outlook, 2023 & 2030
Fig. 37 Regional market dashboard
Fig. 38 Regional market place: Key takeaways
Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 67 Heat map analysis
Fig. 68 Market differentiators
Fig. 1 Transdermal Skin Patches market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Transdermal Skin Patches market: Type movement analysis
Fig. 17 Transdermal Skin Patches market: Type segment dashboard
Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Transdermal Skin Patches market: Application movement analysis
Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Regional outlook, 2023 & 2030
Fig. 37 Regional market dashboard
Fig. 38 Regional market place: Key takeaways
Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 67 Heat map analysis
Fig. 68 Market differentiators
